Aquatic Capital Management LLC Kiniksa Pharmaceuticals, Ltd. Transaction History

Aquatic Capital Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$17.63 - $21.74 $33,497 - $41,306	1,900 Added 22.09%	10,500 $207,000
Q4 2023 Feb 14, 2024	BUY	$14.37 - $19.07 $123,582 - $164,002	8,600 New	8,600 $151,000
Q1 2023 May 15, 2023	SELL	$10.7 - $15.79 $35,310 - $52,107	-3,300 Reduced 84.62%	600 $6,000
Q4 2022 Feb 14, 2023	SELL	$11.42 - $17.05 $75,372 - $112,530	-6,600 Reduced 62.86%	3,900 $58,000
Q3 2022 Nov 14, 2022	BUY	$9.76 - $13.41 $102,480 - $140,805	10,500 New	10,500 $135,000
Q2 2022 Aug 15, 2022	SELL	$7.6 - $11.41 $1,520 - $2,282	-200 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$9.3 - $12.37 $1,860 - $2,474	200 New	200 $2,000

1.95M

Ticker KNSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,470,400
Market Cap $687M
Description
Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...

Get notified when there are updates to the investment portfolio of Aquatic Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aquatic Capital Management LLC with notifications on news.